Literature DB >> 22699754

Tenascin-C produced by oxidized LDL-stimulated macrophages increases foam cell formation through Toll-like receptor-4.

Rui Liu1, Yong He, Bo Li, Jun Liu, Yingang Ren, Wei Han, Xing Wang, Lihua Zhang.   

Abstract

Atherosclerosis is a chronic inflammatory disease in which both innate and adaptive immunity are involved. Although there have been major advances in the involvement of toll-like receptor 4 (TLR4) and CD36 in the initiation and development of this disease, detailed mechanisms remain unknown. Here, we show that tenascin-C (TN-C) can stimulate foam cell formation and this can be inhibited by a TLR4-blocking antibody or CD36 gene silencing. Our results identify TN-C-TLR4 activation as a common molecular mechanism in oxLDL-stimulated foam cell formation and atherosclerosis. In addition, CD36 is the major scavenger receptor responsible for the TN-C-mediated foam cell formation. Taken together, we have identified that TNC produced by oxLDL-stimulated macrophages increases foam cell formation through TLR4 and scavenger receptor CD36.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22699754      PMCID: PMC3887780          DOI: 10.1007/s10059-012-0054-x

Source DB:  PubMed          Journal:  Mol Cells        ISSN: 1016-8478            Impact factor:   5.034


  31 in total

1.  2011 Nobel Prize in Physiology or Medicine: Toll-like receptors, dendritic cells, and their roles in atherosclerosis.

Authors:  Alain Tedgui; A Phillip Owens; Nigel Mackman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-12       Impact factor: 8.311

2.  Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease.

Authors:  Kim Midwood; Sandra Sacre; Anna M Piccinini; Julia Inglis; Annette Trebaul; Emma Chan; Stefan Drexler; Nidhi Sofat; Masahide Kashiwagi; Gertraud Orend; Fionula Brennan; Brian Foxwell
Journal:  Nat Med       Date:  2009-06-28       Impact factor: 53.440

Review 3.  Scavenger receptors: Implications in atherothrombotic disorders.

Authors:  Mohammad Z Ashraf; Neha Gupta
Journal:  Int J Biochem Cell Biol       Date:  2011-02-01       Impact factor: 5.085

4.  Toll-like receptor 4 mediates oxidized LDL-induced macrophage differentiation to foam cells.

Authors:  Kenneth W Howell; Xianzhong Meng; David A Fullerton; Chunhua Jin; T Brett Reece; Joseph C Cleveland
Journal:  J Surg Res       Date:  2011-07-19       Impact factor: 2.192

5.  Vitamin E reduces the uptake of oxidized LDL by inhibiting CD36 scavenger receptor expression in cultured aortic smooth muscle cells.

Authors:  R Ricciarelli; J M Zingg; A Azzi
Journal:  Circulation       Date:  2000-07-04       Impact factor: 29.690

Review 6.  Adaptive immunity in atherosclerosis: mechanisms and future therapeutic targets.

Authors:  Charlotte Lahoute; Olivier Herbin; Ziad Mallat; Alain Tedgui
Journal:  Nat Rev Cardiol       Date:  2011-04-19       Impact factor: 32.419

Review 7.  Adaptive immunity and atherosclerosis.

Authors:  John Andersson; Peter Libby; Göran K Hansson
Journal:  Clin Immunol       Date:  2009-07-26       Impact factor: 3.969

8.  Lipopolysaccharide up-regulates the expression of Fcalpha/mu receptor and promotes the binding of oxidized low-density lipoprotein and its IgM antibody complex to activated human macrophages.

Authors:  Xuyang Feng; Yingmei Zhang; Ruifen Xu; Xin Xie; Ling Tao; Haokao Gao; Yan Gao; Zheng He; Haichang Wang
Journal:  Atherosclerosis       Date:  2009-07-23       Impact factor: 5.162

Review 9.  Expression and immune function of tenascin-C.

Authors:  Irina A Udalova; Michaela Ruhmann; Scott J P Thomson; Kim S Midwood
Journal:  Crit Rev Immunol       Date:  2011       Impact factor: 2.214

Review 10.  Advances in tenascin-C biology.

Authors:  Kim S Midwood; Thomas Hussenet; Benoit Langlois; Gertraud Orend
Journal:  Cell Mol Life Sci       Date:  2011-08-05       Impact factor: 9.261

View more
  9 in total

Review 1.  Toll-like Receptors in the Vascular System: Sensing the Dangers Within.

Authors:  Styliani Goulopoulou; Cameron G McCarthy; R Clinton Webb
Journal:  Pharmacol Rev       Date:  2016-01       Impact factor: 25.468

Review 2.  Damage-associated molecular patterns and their receptors in upper airway pathologies.

Authors:  Koen Van Crombruggen; Fenila Jacob; Nan Zhang; Claus Bachert
Journal:  Cell Mol Life Sci       Date:  2013-05-15       Impact factor: 9.261

Review 3.  Extracellular matrix regulation of inflammation in the healthy and injured spinal cord.

Authors:  Andrew D Gaudet; Phillip G Popovich
Journal:  Exp Neurol       Date:  2014-08       Impact factor: 5.330

Review 4.  Internal Affairs: Tenascin-C as a Clinically Relevant, Endogenous Driver of Innate Immunity.

Authors:  Anna M Marzeda; Kim S Midwood
Journal:  J Histochem Cytochem       Date:  2018-01-31       Impact factor: 2.479

5.  miR-21 attenuates lipopolysaccharide-induced lipid accumulation and inflammatory response: potential role in cerebrovascular disease.

Authors:  Jun Feng; Antai Li; Jingyuan Deng; Yanhua Yang; Lili Dang; Yuanpeng Ye; Yuxin Li; Weiping Zhang
Journal:  Lipids Health Dis       Date:  2014-02-07       Impact factor: 3.876

6.  Transcriptome Profiling of Bovine Macrophages Infected by Mycobacterium avium spp. paratuberculosis Depicts Foam Cell and Innate Immune Tolerance Phenotypes.

Authors:  Olivier Ariel; Daniel Gendron; Pier-Luc Dudemaine; Nicolas Gévry; Eveline M Ibeagha-Awemu; Nathalie Bissonnette
Journal:  Front Immunol       Date:  2020-01-08       Impact factor: 7.561

Review 7.  The Roles of Tenascins in Cardiovascular, Inflammatory, and Heritable Connective Tissue Diseases.

Authors:  Ken-Ichi Matsumoto; Hiroki Aoki
Journal:  Front Immunol       Date:  2020-12-01       Impact factor: 7.561

8.  Identification of molecular subtypes of coronary artery disease based on ferroptosis- and necroptosis-related genes.

Authors:  Wen-Pan Liu; Peng Li; Xu Zhan; Lai-Hao Qu; Tao Xiong; Fang-Xia Hou; Jun-Kui Wang; Na Wei; Fu-Qiang Liu
Journal:  Front Genet       Date:  2022-09-20       Impact factor: 4.772

9.  Tenascin-C drives persistence of organ fibrosis.

Authors:  Swati Bhattacharyya; Wenxia Wang; Luisa Morales-Nebreda; Gang Feng; Minghua Wu; Xiaodong Zhou; Robert Lafyatis; Jungwha Lee; Monique Hinchcliff; Carol Feghali-Bostwick; Katja Lakota; G R Scott Budinger; Kirtee Raparia; Zenshiro Tamaki; John Varga
Journal:  Nat Commun       Date:  2016-06-03       Impact factor: 14.919

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.